PF-04634817 succinate structure
|
Common Name | PF-04634817 succinate | ||
|---|---|---|---|---|
| CAS Number | 2140301-98-8 | Molecular Weight | 629.67 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H36F3N5O3·C4H6O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PF-04634817 succinatePF-04634817 is a potent, orally bioavailble CCR2 and CCR5 chemokine receptor antagonist, for the treatment of diabetic nephropathies and diabetic macular oedema. Other Indication Phase 2 Discontinued |
| Name | PF-04634817 succinate |
|---|
| Description | PF-04634817 is a potent, orally bioavailble CCR2 and CCR5 chemokine receptor antagonist, for the treatment of diabetic nephropathies and diabetic macular oedema. Other Indication Phase 2 Discontinued |
|---|---|
| References | References View Related Products by Target Chemokine Receptor (CCR and CXCR) Other Indication |
| Molecular Formula | C25H36F3N5O3·C4H6O4 |
|---|---|
| Molecular Weight | 629.67 |